Biocompatible glass–ceramic materials for bone substitution

A new bioactive glass composition (CEL2) in the SiO₂–P₂O₅–CaO–MgO–K₂O–Na₂O system was tailored to control pH variations due to ion leaching phenomena when the glass is in contact with physiological fluids. CEL2 was prepared by a traditional melting-quenching process obtaining slices that were heat-treated to obtain a glass-ceramic material (CEL2GC) that was characterized thorough SEM analysis. Pre-treatment of CEL2GC with SBF was found to enhance its biocompatibility, as assessed by in vitro tests. CEL2 powder was then used to synthesize macroporous glass–ceramic scaffolds. To this end, CEL2 powders were mixed with polyethylene particles within the 300–600 μm size-range and then pressed to obtain crack-free compacted powders (green). This was heat-treated to remove the organic phase and to sinter the inorganic phase, leaving a porous structure. The biomaterial thus obtained was characterized by X-ray diffraction, SEM equipped with EDS, density measurement, image analysis, mechanical testing and in vitro evaluation, and found to be a glass–ceramic macroporous scaffold with uniformly distributed and highly interconnected porosity. The extent and size-range of the porosity can be tailored by varying the amount and size of the polyethylene particles.     

High strength bioactive glass-ceramic scaffolds for bone regeneration

This research work is focused on the preparation of macroporous glass-ceramic scaffolds with high mechanical strength, equivalent with cancellous bone. The scaffolds were prepared using an open-cells polyurethane sponge as a template and glass powders belonging to the system SiO₂–P₂O₅–CaO–MgO–Na₂O–K₂O. The glass, named as CEL2, was synthesized by a conventional melting-quenching route, ground and sieved to obtain powders of specific size. A slurry of CEL2 powders, polyvinyl alcohol (PVA) as a binder and water was prepared in order to coat, by a process of impregnation, the polymeric template. A thermal treatment was then used to remove the sponge and to sinter the glass powders, in order to obtain a replica of the template structure. The scaffolds were characterized by means of X-ray diffraction analysis, morphological observations, density measurements, volumetric shrinkage, image analysis, capillarity tests, mechanical tests and in vitro bioactivity evaluation.     

Fabrication and biological characteristics of β-tricalcium phosphate porous ceramic scaffolds reinforced with calcium phosphate glass

The fabrication process, compressive strength and biocompatibility of porous β-tricalcium phosphate (β-TCP) ceramic scaffolds reinforced with 45P₂O₅–22CaO–25Na₂O–8MgO bioglass (β-TCP/BG) were investigated for their suitability as bone engineering materials. Porous β-TCP/BG scaffolds with macropore sizes of 200–500 μm were prepared by coating porous polyurethane template with β-TCP/BG slurry. The β-TCP/BG scaffolds showed interconnected porous structures and exhibited enhanced mechanical properties to those pure β-TCP scaffolds. In order to assess the effects of chemical composition of this bioglass on the behavior of osteoblasts cultured in vitro, porous scaffolds were immersed in simulated body fluid (SBF) for 2 weeks, and original specimens (without soaked in SBF) seeded with MC3T3-E1 were cultured for the same period. The ability of inducing apatite crystals in simulated body fluid and the attachment of osteoblasts were examined. Results suggest that apatite agglomerates are formed on the surface of the β-TCP/BG scaffolds and its Ca/P molar ratio is ~1.42. Controlling the crystallization from the β-TCP/BG matrix could influence the releasing speed of inorganic ions and further adjust the microenvironment of the solution around the β-TCP/BG, which could improve the interaction between osteoblasts and the scaffolds.     

Nucleation and growth mechanism of apatite on a bioactive and degradable ceramic/polymer composite with a thick polymer layer

Nucleation and growth mechanism of apatite on a bioactive and degradable PLLA/SiO₂–CaO composite with a thick PLLA surface layer were investigated compared to that on a bioactive but non-degradable polyurethane (PU)/SiO₂–CaO composite with a thick PU surface layer. The bioactive SiO₂–CaO particles were made by a sol–gel method from tetraethyl orthosilicate and calcium nitrate tetrahydrate under acidic condition followed by heat treatment at 600 °C for 2 h. The PLLA/SiO₂–CaO and PU/SiO₂–CaO composites were then prepared by a solvent casting method which resulted in thick PLLA and PU surface layers, respectively, due to precipitation of SiO₂–CaO particles during the casting process. Two composites were exposed to SBF for 1 week and this exposure led to form uniform and complete apatite coating layer on the PLLA/SiO₂–CaO composite but not on the PU/SiO₂-CaO composite. These results were interpreted in terms of the degradability of the polymers. A practical implication of the results is that a post-surface grinding or cutting processes to expose bioactive ceramics to the surface of a composite with a thick biodegradable polymer layer is not required for providing apatite forming ability, which has been considered as one of the pragmatic obstacles for the application as a bone grafting material.     

In vitro studies of novel CaO–SiO2–MgO system composite bioceramics

In this study, a series of CaO–SiO₂–MgO composites with different β-CaSiO₃ (CS)/Mg₂SiO₄ (M₂S) composite ratios were prepared to produce new bioactive and biodegradable biomaterials for potential bone repair. The mechanical properties of CS–M₂S composites increased steadily with the increase of M₂S ratios in composites. Dissolution tests in Tris–HCl buffer solution showed obvious differences with different CS initial composite ratio in composites. The dissolution rate increased with the increase of CS composite ratio, which suggested that the solubility of composites could be tailored by adjusting the initial CS/M₂S composite ratio. Formation of bone-like apatite on a range of CS–M₂S composites with CS weight percentage ranging from 0 to 100 has been investigated in simulated body fluid (SBF). The presence of bone-like apatite layer on the composite surface after soaking in SBF was demonstrated by X-ray diffraction (XRD), field emission scanning electron microscopy (FESEM). The results showed that the apatite formation ability of the CS–M₂S composite with 70% CS was detected after 10 days immersion. In vitro cell experiments showed that the 50 and 70% CS composites supported greater osteoblast-like cell proliferation as compared with pure M₂S (p < 0.05). The results of this study suggested that the CS–M₂S composites with 50 and 70% initial CS composite amount might be more suitable for preparation of bone repair materials.     

Dissolution behavior and bioactivity study of glass ceramic scaffolds in the system of CaO–P2O5–Na2O–ZnO prepared by sol–gel technique

Three-dimensional glass ceramic scaffolds from the system CaO–P₂O₅–Na₂O–ZnO have been prepared by coating polyurethane foams with sol–gel derived glass slurry. Main phase catena hexaphosphate (Ca₄P₆O₁₉), minor phases calcium pyrophosphate (β-Ca₂P₂O₇) and calcium metaphosphate (β-Ca(PO₃)₂) were detected in the prepared glass ceramics. In order to assess the potential use in hard tissue engineering, the dissolution and precipitation behavior of the glass ceramics was investigated in vitro after soaking in simulated body fluid (SBF) for different periods of time, and the bioactivity and biocompatibility studies were conducted using mouse MC3T3-E1. Ca₄P₆O₁₉ phase showed a good chemical durability in SBF solution over the period time of soaking. However, there were small quantities of apatite-like deposits formed on the surfaces after soaking 28 days, exhibiting a poor ability of inducing calcification in SBF. In vitro cell culture, a high degree of cell adhesion and spreading was achieved and large number of mineralized deposits composed of Ca, P and Zn were detected in these porous scaffolds. These results confirmed the biocompatibility and bioactivity of the glass ceramics and the positive effects on mouse MC3T3-E1 cell behavior although no continuous apatite layer was formed on scaffold surfaces after soaking in SBF, and also demonstrated that Zn doped this glass ceramics could strongly stimulate the formation of mineralized deposits in vitro culture of MC3T3-E1 cells.     

Microstructural and <Emphasis Type="Italic">in vitro</Emphasis> characterization of SiO<Subscript>2</Subscript>-Na<Subscript>2</Subscript>O-CaO-MgO glass-ceramic bioactive scaffolds for bone substitutes

In the present research work, the preparation and characterization of bioactive glass-ceramic scaffolds for bone substitutes are described. The scaffolds were prepared by starch consolidation of bioactive glass powders belonging to the SiO₂-Na₂O-CaO-MgO system using three different organic starches (corn, potatoes and rice) as reported in a previous screening process [1]. The scaffolds, characterized by scanning electron microscopy, showed a porous structure with highly interconnected pores. The pores sizes assessed by mercury intrusion porosimetry put in evidence the presence of pores of 50–100 μm. The structure of the scaffolds was investigated by X-ray diffraction and revealed the glass-ceramic nature of the obtained material. The mechanical properties of the scaffolds were evaluated by means of compressive tests on cubic samples and the obtained results demonstrated their good mechanical strength. The in vitro bioactivity of the scaffolds was tested by soaking them in a simulated body fluid (SBF) and by subsequently characterizing the soaked surfaces by SEM, EDS and X-ray diffraction. Good in vitro bioactivity was found for the starting glass and for the obtained scaffolds. Moreover, the scaffold bioresorption, tested by measuring the samples weight loss in SBF at different periods of time, showed a partial resorption of the scaffolds. Cell culture testing of the three different scaffolds indicated no differences in cell number and in alkaline phosphatase activity; the morphology of the osteoblasts showed good spreading, comparable to bulk material which was used as the control.     

Bioactive borate glass scaffolds: in vitro and in vivo evaluation for use as a drug delivery system in the treatment of bone infection

The objective of this work was to evaluate borate bioactive glass scaffolds (with a composition in the system Na₂O–K₂O–MgO–CaO–B₂O₃–P₂O₅) as devices for the release of the drug Vancomycin in the treatment of bone infection. A solution of ammonium phosphate, with or without dissolved Vancomycin, was used to bond borate glass particles into the shape of pellets. The in vitro degradation of the pellets and their conversion to a hydroxyapatite-type material in a simulated body fluid (SBF) were investigated using weight loss measurements, chemical analysis, X-ray diffraction, and scanning electron microscopy. The results showed that greater than 90% of the glass in the scaffolds degraded within 1 week, to form poorly crystallized hydroxyapatite (HA). Pellets loaded with Vancomycin provided controlled release of the drug over 4 days. Vancomycin-loaded scaffolds were implanted into the right tibiae of rabbits infected with osteomyelitis. The efficacy of the treatment was assessed using microbiological examination and histology. The HA formed in the scaffolds in vivo, resulting from the conversion of the glass, served as structure to support the growth of new bone and blood vessels. The results in this work indicate that bioactive borate glass could provide a promising biodegradable and bioactive material for use as both a drug delivery system and a scaffold for bone repair.     

Glass–ceramic scaffolds containing silica mesophases for bone grafting and drug delivery

Glass–ceramic macroporous scaffolds were prepared using glass powders and polyethylene (PE) particles of two different sizes. The starting glass, named as Fa-GC, belongs to the system SiO₂–P₂O₅–CaO–MgO–Na₂O–K₂O–CaF₂ and was synthesized by a traditional melting-quenching route. The glass was ground and sieved to obtain powders of specific size which were mixed with PE particles and then uniaxially pressed in order to obtain crack-free green samples. The compact of powders underwent a thermal treatment to remove the organic phase and to sinter the Fa-GC powders. Fa-GC scaffolds were characterized by means of X-Ray Diffraction, morphological observations, density measurements, image analysis, mechanical tests and in vitro tests. Composite systems were then prepared combining the drug uptake-delivery properties of MCM-41 silica micro/nanospheres with the Fa-GC scaffold. The system was prepared by soaking the scaffold into the MCM-41 synthesis batch. The composite scaffolds were characterized by means of X-Ray Diffraction, morphological observations, mechanical tests and in vitro tests. Ibuprofen was used as model drug for the uptake and delivery analysis of the composite system. In comparison with the MCM-41-free scaffold, both the adsorption capacity and the drug delivery behaviour were deeply affected by the presence of MCM-41 spheres inside the scaffold.     

Fabrication of bioactive composite by developing PLLA onto the framework of sintered HA scaffold

Composite porous scaffolds of hydroxyapatite (HA)/poly-l-lactide (PLLA) were fabricated by a two-step immersing replication method. Structure and mechanical properties of both the single HA scaffold and the composite HA/PLLA scaffold were determined. The bioactivity of the scaffolds was evaluated by soaking in a simulated body fluid (SBF), and the formation of the apatite layer was determined by X-ray diffraction (XRD), Scanning Electron Microscope (SEM) and Energy-Dispersive Spectrometer (EDS). The results showed that without changing the highly interconnected porous structure, the HA/PLLA composite scaffold was mechanically enhanced to a great deal of extent compared with single HA scaffold. On the other hand, it is also suggested that the HA/PLLA scaffold was bioactive as it induced the formation of apatite on the surface of the composite scaffolds after soaking in SBF for 7 days.     

Bioresorbable and bioactive composite materials based on polylactide foams filled with and coated by Bioglass® particles for tissue engineering applications

Poly(DL-lactide) (PDLLA) foams and bioactive glass (Bioglass®) particles were used to form bioresorbable and bioactive composite scaffolds for applications in bone tissue engineering. A thermally induced phase separation process was applied to prepare highly porous PDLLA foams filled with 10 wt % Bioglass® particles. Stable and homogeneous layers of Bioglass® particles on the surface of the PDLLA/Bioglass® composite foams as well as infiltration of Bioglass® particles throughout the porous network were achieved using a slurry-dipping technique. The quality of the bioactive glass coatings was reproducible in terms of thickness and microstructure. In vitro studies in simulated body fluid (SBF) were performed to study the formation of hydroxyapatite (HA) on the surface of the PDLLA/Bioglass® composites, as an indication of the bioactivity of the materials. Formation of the HA layer after immersion in SBF was confirmed by X-ray diffraction and Raman spectroscopy measurements. The rate of HA formation in Bioglass®-coated samples was higher than that observed in non-coated samples. SEM analysis showed that the HA layer thickness rapidly increased with increasing time in SBF in the Bioglass®-coated samples. The high bioactivity of the developed composites suggests that the materials are attractive for use as bioactive, resorbable scaffolds in bone tissue engineering.     

Mechanical and in vitro performance of apatite–wollastonite glass ceramic reinforced hydroxyapatite composite fabricated by 3D-printing

In situ hydroxyapatite/apatite–wollastonite glass ceramic composite was fabricated by a three dimensional printing (3DP) technique and characterized. It was found that the as-fabricated mean green strength of the composite was 1.27 MPa which was sufficient for general handling. After varying sintering temperatures (1050–1300°C) and times (1–10 h), it was found that sintering at 1300°C for 3 h gave the greatest flexural modulus and strength, 34.10 GPa and 76.82 MPa respectively. This was associated with a decrease in porosity and increase in densification ability of the composite resulting from liquid phase sintering. Bioactivity tested by soaking in simulated body fluid (SBF) and In Vitro toxicity studies showed that 3DP hydroxyapatite/A–W glass ceramic composite was non-toxic and bioactive. A new calcium phosphate layer was observed on the surface of the composite after soaking in SBF for only 1 day while osteoblast cells were able to attach and attain normal morphology on the surface of the composite.     

Sol–gel derived composite from bioactive glass–polyvinyl alcohol

Investigation of novel biomaterials for bone engineering is based on the development of porous scaffolds, which should match the properties of the tissue that is to be replaced. These materials need to be biocompatible, ideally osteoinductive, osteoconductive, and mechanically well-matched. In the present paper, we report the preparation and characterization of hybrid macroporous scaffold of polyvinyl alcohol (PVA)/bioactive glass through the sol–gel route. Hybrids containing PVA (80, 70 and 60 wt%) and bioactive glass with composition 58SiO₂–33CaO–9P₂O₅ were synthesized by foaming a mixture of polymer solution and bioactive glass via sol–gel precursor solution. PVA with two different degree of hydrolysis (DH), 98.5% (high degree) and 80% (low degree) were also investigated, in order to evaluate the influence of residual acetate group present in polymer chain on the final structure and properties of 3D porous composite produced. The microstructure, morphology and crystallinity of the hybrid porous scaffolds were characterized by X-ray diffraction (XRD), Infrared Fourier Transform spectrometry (FTIR) and Scanning electron microscopy (SEM/EDX) analysis. In addition, specific surface area was assessed by B.E.T. nitrogen adsorption method and mechanical behavior was evaluated by compression tests. Preliminary cytotoxicity and cell viability were also performed by the MTT assay. VERO cell monolayers were grown in 96-well microtiter plates. The results have clearly showed that hybrid foams of polyvinyl alcohol/bioactive glass (PVA/BG) with interconnected macroporous 3D structure were successfully produced. All the tested hybrids of PVA/BG have showed adequate cell viability properties for potential biological applications.     

Electrophoretic deposition of porous CaO–MgO–SiO<Subscript>2</Subscript> glass–ceramic coatings with B<Subscript>2</Subscript>O<Subscript>3</Subscript> as additive on Ti–6Al–4V alloy

The sub-micron glass–ceramic powders in CaO–MgO–SiO₂ system with 10 wt% B₂O₃ additive were synthesized by sol–gel process. Then bioactive porous CaO–MgO–SiO₂ glass–ceramic coatings on Ti–6Al–4V alloy substrates were fabricated using electrophoretic deposition (EPD) technique. After being calcined at 850°C, the above coatings with thickness of 10–150 μm were uniform and crack-free, possessing porous structure with sub-micron and micron size connected pores. Ethanol was employed as the most suitable solvent to prepare the suspension for EPD. The coating porous appearance and porosity distribution could be controlled by adjusting the suspension concentration, applied voltage and deposition time. The heat-treated coatings possessed high crystalline and was mainly composed of diopside, akermanite, merwinite, calcium silicate and calcium borate silicate. Bonelike apatite was formed on the coatings after 7 days of soaking in simulated body fluid (SBF). The bonding strength of the coatings was needed to be further improved.     

Magnetic bioactive glass ceramic in the system CaO-P2O5-SiO2-MgO-CaF2-MnO2-Fe2O3 for hyperthermia treatment of bone tumor

Magnetic bioactive glass ceramic (MG) in the system CaO–SiO₂–P₂O₅–MgO–CaF₂–MnO₂–Fe₂O₃ for hyperthermia treatment of bone tumor was synthesized. The phase composition was investigated by XRD. The magnetic property was measured by VSM. The in vitro bioactivity was investigated by simulated body fluid (SBF) soaking experiment. Cell growth on the surface of the material was evaluated by co-culturing osteoblast-like ROS17/2.8 cells with materials for 7 days. The results showed that MG contained CaSiO₃ and Ca₅(PO₄)₃F as the main phases, and MnFe₂O₄ and Fe₃O₄ as the magnetic phases. Under a magnetic field of 10,000 Oe, the saturation magnetization and coercive force of MG were 6.4 emu/g and 198 Oe, respectively. After soaking in SBF for 14 days, hydroxyapatite containing CO₃ ²⁻ was observed on the surface of MG. The experiment of co-culturing cells with material showed that cells could successfully attach and well proliferate on MG.     

Porous calcium phosphate ceramics modified with PLGA–bioactive glass

Porous calcium phosphate ceramics (mainly hydroxyapatite) with interconnected macropores (∼1 mm) and micropores (∼5 μm) as well as high porosities (∼80%) were prepared by firing polyurethane foams that were coated with calcium phosphate cement at 1200 °C. In order to improve the mechanical properties such as compressive strength and compressive modulus and maintain the desirable bioactivity (i.e. the ability of apatite layer formation), the open micropores of the struts were infiltrated with poly(lactic-co-glycolic acid) (PLGA) to achieve an interpenetrating bioactive ceramic/biodegradable polymer composite structure. The PLGA filled struts were further coated with a 58S bioactive glass (33 wt.%)–PLGA composite coating. The PLGA–bioactive glass modified porous calcium phosphate ceramics proved to be bioactive and exhibited compressive strengths up to 7.7 MPa and compressive moduli up to 3 GPa, which were comparable to those of natural spongy bones. The obtained complex porous bioactive/biodegradable composites could be used as tissue engineering scaffolds for low-load bearing applications.     

Fabrication and characterization of bioactive silk fibroin/wollastonite composite scaffolds

Composite scaffolds of silk fibroin (SF) with bioactive wollastonite were prepared by freeze-drying. X-ray diffraction (XRD) and Fourier transform infrared (FT-IR) spectroscopy analysis showed that random coil and β-sheet structure co-existed in the SF scaffold. The mechanical performance, surface hydrophilicity and water-uptake capacity of the composite scaffolds were improved compared with those of pure SF scaffold. The bioactivity of the composite scaffold was evaluated by soaking in a simulated body fluid (SBF), and formation of a hydroxycarbonate apatite (HCA) layer was determined by FT-IR and XRD. The results showed that the SF/wollastonite composite scaffold was bioactive as it induced the formation of HCA on the surface of the composite scaffold after soaking in SBF for 5 days. In vitro cell attachment and proliferation tests showed that the composite scaffold was a good matrix for the growth of L929 mouse fibroblast cells. Consequently, the incorporation of wollastonite into the SF scaffold can enhance both the mechanical strength and bioactivity of the scaffold, which suggests that the SF/wollastonite composite scaffold may be a potential biomaterial for tissue engineering.     

Biodegradable polyurethane composite scaffolds containing Bioglass® for bone tissue engineering

Five types of solid and porous polyurethane composites containing 5–20 wt.% of Bioglass® inclusions were synthesized. Porous structures were fabricated by polymer coagulation combined with the salt-particle leaching method. In-vitro bioactivity tests in simulated body fluid (SBF) were carried out and the marker of bioactivity, e.g. formation of surface hydroxyapatite or calcium phosphate layers upon immersion in SBF, was investigated. The chemical and physical properties of the solid and porous composites before and after immersion in SBF were evaluated using different techniques: Fourier Transform Infrared Spectroscopy (FTIR), Differential Scanning Calorimetry (DSC), Dynamic Mechanical Analysis (DMA) and Thermogravimetric Analysis (TGA). Moreover the surface structure and microstructure of the composites was characterised by Atomic Force Microscopy (AFM) and Scanning Electron Microscopy (SEM), respectively. Mercury intrusion porosimetry, SEM and microtomography (μCT) were used to determine pore size distribution and porosity. The fabricated foams exhibited porosity >70% with open pores of 100–400 μm in size and pore walls containing numerous micropores of <10 μm. This pore structure satisfies the requirements for bone tissue engineering applications. The effects of Bioglass® addition on microstructure, mechanical properties and bioactivity of polyurethane scaffolds were evaluated. It was found that composite foams showed a higher storage modulus than neat polyurethane foams. The high bioactivity of composite scaffolds was confirmed by the rapid formation of hydroxyapatite on the foam surfaces upon immersion in SBF.     

Preparation and HL-7702 cell functionality of titania/chitosan composite scaffolds

Titania/chitosan composite scaffolds were prepared through a freeze-drying technique. The composite scaffolds were highly porous with the average pore size of 120–300 μm, and the titania (TiO₂) powders were uniformly dispersed on the surface of the pore walls. The compressive strength of the composite scaffolds was significantly improved compared to that of pure chitosan scaffolds. Composite scaffold with 0.3 of TiO₂/chitosan weight ratio showed the maximum compressive strength of 159.7 ± 21 kPa. Hepatic immortal cell line HL-7702 was used as seeding cells on the scaffolds, and after different culture periods, cell attachment and function was analyzed. HL-7702 cells attached on the pore walls of the scaffolds with the spheroid shape after 1 day of culture, but more cell aggregations formed within the TiO₂/chitosan composite scaffolds as compared to pure chitosan scaffolds. Liver-specific functions, albumin secretion and urea synthesis were detected using a spectrometric method. The results showed that albumin secretion and urea synthesis rate of HL-7702 cells slightly decreased with the culture time, and there was no significant difference between composite scaffolds and pure chitosan scaffolds. In conclusion, the TiO₂/chitosan composite scaffolds possessed an improved mechanical strength compared to pure chitosan scaffolds and supported the attachment and functional expression of hepatocyte, implying their potential application in liver tissue engineering.     

Fabrication and characterization of silk fibroin/bioactive glass composite films

Composite films of silk fibroin (SF) with nano bioactive glass (NBG) were prepared by the solvent casting method, and the structures and properties of the composite films were characterized. Fourier transform infrared (FT-IR) spectroscopy analysis shows that the random coil and β-sheet structure co-exist in the SF films. Results of field emission scanning electron microscope (FESEM) indicate that the NBG particles are uniformly dispersed in the SF films. The measurements of the water contact angles suggest that the incorporation of NBG into SF can improve the hydrophilicity of the composites. The bioactivity of the composite films was evaluated by soaking in 1.5 times simulated body fluid (1.5 × SBF), and formation of a hydroxycarbonate apatite (HCA) layer was determined by XRD and FESEM. The results show that the SF/NBG composite film is bioactive as it induces the formation of HCA on the surface of the composite film after soaking in 1.5 × SBF for 7 days. In vitro osteoblasts attachment and proliferation tests show that the composite film is a good matrix for the growth of osteoblasts. Consequently, the incorporation of NBG into the SF film can enhance both the bioactivity and biocompatibility of the film, which suggests that the SF/NBG composite film may be a potential biomaterial for bone tissue engineering.